Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance. - Jane EP; Premkumar DR; Thambireddy S; Golbourn B; Agnihotri S; Bertrand KC; Mack SC; Myers MI; Chattopadhyay A; Taylor DL; Schurdak ME; Stern AM; et al. (Molecular cancer research : MCR, 2020)